Loading...

RASSF1A promoter methylation correlates development, progression, and poor cancer-specific survival of renal cell carcinoma: trial sequential analysis

BACKGROUND: This meta-analysis evaluated the clinicopathologic and prognostic significance of RASSF1A promoter methylation in renal cell carcinoma (RCC). MATERIALS AND METHODS: The ORs or HRs and their 95% CIs were calculated. Trial sequential analysis was conducted. RESULTS: Twenty-two articles tha...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Onco Targets Ther
Main Authors: Zhuang, Qianfeng, Chen, Zhen, Shen, Jie, Fan, Min, Xue, Dong, Lu, Hao, Xu, Renfang, He, Xiaozhou
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6304251/
https://ncbi.nlm.nih.gov/pubmed/30588036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S183142
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!